Close Menu

In-vivo

The Application Methods of MAPKs Signal Pathway Inhibitor SP600125 and SB203580 in Long-term In-vivo Experiments

Issue: 
DOI: 
10.7727/wimj.2015.487
Pages: 
98-104
Synopsis: 
The intravenous injection of mitogen-activated protein kinase inhibitors SP600125 and SB203580 for four weeks significantly reduced the phosphorylation levels of JNK and p38 in vivo.

ABSTRACT

Objective: To explore the application methods of MAPK signal pathway inhibitor SP600125 and SB203580’s long-term experiments in vivo.

Accepted: 
30 Sep, 2015
PDF Attachment: 
Journal Sections: 
e-Published: 15 Jan, 2016
Subscribe to RSS - In-vivo
Top of Page